SAMUEL P. WERTHEIMER

Profile

First Name

: SAMUEL

Middle Name

: P.

Last Name

: WERTHEIMER

Related Companies

Titles

Company Name

Related People

DIRECTOR

NEURAXON(USA), INC.

JOHN S. ANDREWS, LAWRENCE E. BLOCH, AARON DAVIDSON, KENNETH GALBRAITH, JONATHAN R. GOODMAN, TOM LATEGAN, SHAWN MADDAFORD, ROBERT A. MEDVE, DEEPA PAKIANATHAN, SUMAN RAKHIT, ANDREW SANDHAM

DIRECTOR

CERIMON PHARMACEUTICALS, INC.

ROBERT ADELMAN, ANSBERT GADICKE, PAUL HASTINGS, VAUGHN KAILIAN, MATTHEW J. MEYER, GARY PATOU, DENISE POLLARD-KNIGHT, JAMES SHANNON, JAMES S. SHANNON, JAMES H. WELCH

EXECUTIVE OFFICER

POLIWOGG HOLDINGS, INC.

JEFFREY L. FELDMAN, LESLIE FUNTLEYDER, DAVID W. JAFFIN, ERNEST LUDY, DENNIS J. PURCELL, GREGORY C. SIMON, TOMMY G. THOMPSON, SHERYL WUDUNN

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

INVESTMENT BANKING

DECLINE TO DISCLOSE

Equity

2013-01-03

D/A

INVESTMENT BANKING

DECLINE TO DISCLOSE

Equity

2013-01-03

D/A

INVESTMENT BANKING

DECLINE TO DISCLOSE

Equity

2013-01-03

D/A

INVESTMENT BANKING

DECLINE TO DISCLOSE

Equity

2013-01-03

D/A

INVESTMENT BANKING

DECLINE TO DISCLOSE

Equity

2013-01-03

D

INVESTMENT BANKING

DECLINE TO DISCLOSE

Equity

2013-01-03

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2010-11-01

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2010-10-01

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2010-03-30

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2010-03-30

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2009-12-21